Medeon Biodesign (ROCO:6499) GF Value Rank: 2 (As of Aug. 15, 2026) — 60% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6499 Medeon Biodesign Inc ROCO:6499
61 GF Score
Price NT$66.80
GF Value NT$107.24
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Medeon Biodesign GF Value Rank?

Medeon Biodesign ROCO:6499 +9.15% 61 GF Value Rank is 2 as of Aug. 15, 2026, which is 60% below its 10-year median of 5.00. GuruFocus rates ROCO:6499 with a GF Score™ of 61/100 and a GF Value™ of NT$107.24 (Possible Value Trap). The stock has 2 warning signs investors should review.

Medeon Biodesign has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Medeon Biodesign GF Value Rank Related Terms


ROCO:6499 vs ISRG, BDX, MDLN: GF Value Rank Comparison

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign GF Value Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's GF Value Rank falls into.


ROCO:6499
61GF Score
Medeon Biodesign Inc ROCO:6499
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
Medeon Biodesign (ROCO:6499) has a GF Value Rank of 2 as of Aug. 15, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Medeon Biodesign and its competitors. This is 60% below median its historical median of 5.00. Over the past decade, Medeon Biodesign's GF Value Rank has ranged from 1.00 to 10.00.
Is Medeon Biodesign's GF Value Rank too high?
Medeon Biodesign's current GF Value Rank of 2 is 60% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Medeon Biodesign has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medeon Biodesign's GF Value Rank compare to ISRG and BDX?
Medeon Biodesign's GF Value Rank of 2 can be compared against companies in the Medical Devices & Instruments industry. Historically, Medeon Biodesign's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Devices & Instruments company?
A good GF Value Rank depends on the Medical Devices & Instruments industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Medeon Biodesign and its competitors. Medeon Biodesign's current GF Value Rank is 2, which is 60% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeon Biodesign stock overvalued right now?
Based on GuruFocus' analysis, Medeon Biodesign (ROCO:6499) is currently considered Possible Value Trap. The stock's GF Value™ is NT$107.24, compared to a current price of NT$66.80 — trading 37.7% below its estimated fair value. The current GF Value Rank is 2, which is 60% below median its 10-year median of 5.00. Medeon Biodesign's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Medeon Biodesign (ROCO:6499), the current GF Value Rank is 2 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medeon Biodesign (ROCO:6499) Overvalued in 2026?

Based on GuruFocus' analysis, Medeon Biodesign stock appears to be undervalued. The current stock price of NT$66.80 is trading 37.7% below its estimated GF Value™ of NT$107.24. GuruFocus considers Medeon Biodesign to be Possible Value Trap.

Key valuation signals for ROCO:6499:

  • GF Value Rank: 2 (60% below median its 10-year median of 5.00)
  • GF Value™: NT$107.24 vs. price of NT$66.80 (37.7% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medeon Biodesign Business Description

Address No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
61GF Score

Get the complete analysis for ROCO:6499

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$66.80
Price
NT$107.24
GF Value